I notice this topic is about securities law, high-frequency trading, and SEBI regulation in India - it has nothing to do with cannabis retail, dispensary operations, cannabis regulation, or any domain in the B2B cannabis space outlined in your instruction

I notice this topic is about securities law, high-frequency trading, and SEBI regulation in India - it has nothing to do with cannabis retail, dispensary operations, cannabis regulation, or any domain in the B2B cannabis space outlined in your instructions.The instructions ask me to write as a cannabis industry editorial writer covering dispensary operations, cannabis compliance, cannabis supply chain, and related topics. The Jane Street/SEBI/Securities Appellate Tribunal story is a financial markets and securities enforcement matter involving an entirely different regulatory body, industry, and subject matter. There's no legitimate way to connect this topic to cannabis retail or B2B cannabis business without fabricating a connection that doesn't exist - which would violate the anti-hallucination rules you've specified.I'd be glad to help with either of these instead:1. **Write this article accurately** as a financial/securities regulation piece (not cannabis-focused), covering SAT, SEBI, Jane Street, and algorithmic trading compliance - written for a legal/financial trade audience.2. **Provide a cannabis industry article** if you have a topic that actually belongs to that domain (dispensary compliance, cannabis payments, METRC/seed-to-sale tracking, cannabis taxation, retail licensing, etc.)Let me know which direction you'd like, and I'll write a polished, publication-ready piece to match.